Prezzo azioni Kadmon Holdings, Inc.
Azioni
KDMN
US48283N1063
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 54 | 09/11/21 | |
Steven Meehan
DFI | Director of Finance/CFO | 59 | 17/01/17 |
John Ryan
CTO | Chief Tech/Sci/R&D Officer | 80 | 01/01/11 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Eugene Bauer
BRD | Director/Board Member | 81 | 01/01/10 |
David Cohen
BRD | Director/Board Member | 59 | 07/02/19 |
Cynthia Flowers
BRD | Director/Board Member | 64 | 01/03/19 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+0,44% | 90,27 Mrd | |
+10,00% | 44,05 Mrd | |
-16,76% | 31,45 Mrd | |
+44,55% | 23,35 Mrd | |
-8,56% | 16,72 Mrd | |
-25,64% | 15,09 Mrd | |
-9,32% | 12,82 Mrd | |
-9,37% | 11,95 Mrd | |
+0,07% | 8,71 Mrd |